A First-in-Human Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Novel Anti-Interleukin 1 Biologic Agent, Rph-104, in Healthy Subjects


Gül A., Ulker S., Senturk R. S. , Turk U. O. , GÜRGÜN C. , Lavrovsky Y., ...Daha Fazla

ARTHRITIS & RHEUMATOLOGY, cilt.69, 2017 (SCI İndekslerine Giren Dergi) identifier

  • Cilt numarası: 69
  • Basım Tarihi: 2017
  • Dergi Adı: ARTHRITIS & RHEUMATOLOGY